These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 7504152)
1. Sustained c-kit expression in a human erythroleukemia cell line (HEL) after megakaryocytic differentiation induced by 12-O-tetradecanoylphorbol-13-acetate (TPA). Bakić M; Ozawa K; Uemura N; Nishikawa M; Tojo A; Takahashi K; Tani K; Zaike Y; Ikebuchi K; Asano S Leuk Res; 1993 Dec; 17(12):1079-82. PubMed ID: 7504152 [TBL] [Abstract][Full Text] [Related]
2. Phorbol ester 12-O-tetradecanoylphorbol-13-acetate down-regulates expression of the c-kit proto-oncogene product. Asano Y; Brach MA; Ahlers A; de Vos S; Butterfield JH; Ashman LK; Valent P; Gruss HJ; Herrmann F J Immunol; 1993 Sep; 151(5):2345-54. PubMed ID: 7689605 [TBL] [Abstract][Full Text] [Related]
3. Analysis of c-kit expression of human erythroleukemia cell line, HEL: clonal variation and relationship with erythroid and megakaryocytic phenotype. Kubota A; Okamura S; Shimoda K; Ikematsu W; Otsuka T; Niho Y Leuk Res; 1995 Apr; 19(4):283-90. PubMed ID: 7538619 [TBL] [Abstract][Full Text] [Related]
5. A plant steroid, diosgenin, a new megakaryocytic differentiation inducer of HEL cells. Beneytout JL; Nappez C; Leboutet MJ; Malinvaud G Biochem Biophys Res Commun; 1995 Feb; 207(1):398-404. PubMed ID: 7857294 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of protein kinase C suppresses megakaryocytic differentiation and stimulates erythroid differentiation in HEL cells. Hong Y; Martin JF; Vainchenker W; Erusalimsky JD Blood; 1996 Jan; 87(1):123-31. PubMed ID: 8547633 [TBL] [Abstract][Full Text] [Related]
7. Expression of stem cell factor and c-kit in human neuroblastoma. The Children's Cancer Group. Cohen PS; Chan JP; Lipkunskaya M; Biedler JL; Seeger RC Blood; 1994 Nov; 84(10):3465-72. PubMed ID: 7524740 [TBL] [Abstract][Full Text] [Related]
8. c-sis/platelet-derived growth factor-B promoter requirements for induction during the 12-O-tetradecanoylphorbol-13-acetate-mediated megakaryoblastic differentiation of K562 human erythroleukemia cells. Kujoth GC; Fahl WE Cell Growth Differ; 1997 Sep; 8(9):963-77. PubMed ID: 9300179 [TBL] [Abstract][Full Text] [Related]
9. Aphidicolin, an inhibitor of DNA replication, blocks the TPA-induced differentiation of a human megakaryoblastic cell line, MEG-O1. Murate T; Hotta T; Tsushita K; Suzuki M; Yoshida T; Saga S; Saito H; Yoshida S Blood; 1991 Dec; 78(12):3168-77. PubMed ID: 1742484 [TBL] [Abstract][Full Text] [Related]
10. Megakaryocytic differentiation of a leukemic cell line, MC3, by phorbol ester: induction of glycoprotein IIb/IIIa and effects on expression of IL-6, IL-6 receptor, mpl and GATA genes. Okabe M; Kunieda Y; Shoji M; Nakane S; Kurosawa M; Tanaka J; Hansen SR; Asaka M Leuk Res; 1995 Dec; 19(12):933-43. PubMed ID: 8632663 [TBL] [Abstract][Full Text] [Related]
11. Downregulation of GATA-1 expression during phorbol myristate acetate-induced megakaryocytic differentiation of human erythroleukemia cells. Dai W; Murphy MJ Blood; 1993 Mar; 81(5):1214-21. PubMed ID: 8443382 [TBL] [Abstract][Full Text] [Related]
12. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells. Cupit LD; Schmidt VA; Gnatenko DV; Bahou WF Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554 [TBL] [Abstract][Full Text] [Related]
13. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885 [TBL] [Abstract][Full Text] [Related]
14. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7. Orlic D; Anderson S; Biesecker LG; Sorrentino BP; Bodine DM Proc Natl Acad Sci U S A; 1995 May; 92(10):4601-5. PubMed ID: 7538677 [TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2. Abe A; Emi N; Kato H; Adachi K; Murate T; Saga S; Ogura M; Kojima T; Tanimoto M; Morishita N Leukemia; 1995 Feb; 9(2):341-9. PubMed ID: 7869773 [TBL] [Abstract][Full Text] [Related]
16. Gene expression during phorbol ester-induced differentiation of cultured human megakaryoblastic cells. Dorn GW; Davis MG; D'Angelo DD Am J Physiol; 1994 May; 266(5 Pt 1):C1231-9. PubMed ID: 8203487 [TBL] [Abstract][Full Text] [Related]
18. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point. Gogusev J; Barbey S; Nezelof C Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523 [TBL] [Abstract][Full Text] [Related]
19. The Wsh and Ph mutations affect the c-kit expression profile: c-kit misexpression in embryogenesis impairs melanogenesis in Wsh and Ph mutant mice. Duttlinger R; Manova K; Berrozpe G; Chu TY; DeLeon V; Timokhina I; Chaganti RS; Zelenetz AD; Bachvarova RF; Besmer P Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3754-8. PubMed ID: 7537375 [TBL] [Abstract][Full Text] [Related]
20. Modulation of GM-CSF receptor beta-subunit and interleukin-6 receptor mRNA expression in a human megakaryocytic leukemia cell line. Yasunaga M; Ryo R; Yamaguchi N Leuk Lymphoma; 1992 Nov; 8(4-5):397-403. PubMed ID: 1290964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]